Rachel Kerr
- Oncology top 0.5%
- Molecular Biology top 5%
- Pathology and Forensic Medicine top 0.5%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Rachel MidgleyLawrence S. YoungIan TomlinsonElaine JohnstoneAxel WaltherCharles SwantonDavid A. AndersonAristides G. Eliopoulos
- Topics
- Colorectal Cancer Treatments and Studies (70 papers)Genetic factors in colorectal cancer (44 papers)Colorectal Cancer Surgical Treatments (28 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Rachel Kerr
143 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Oncology 3.3k
- Molecular Biology 2.4k
- Pathology and Forensic Medicine 1.3k
- Cancer Research 987
- Pulmonary and Respiratory Medicine 793
Countries citing papers authored by Rachel Kerr
This map shows the geographic impact of Rachel Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Kerr more than expected).
Fields of papers citing papers by Rachel Kerr
This network shows the impact of papers produced by Rachel Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Kerr. The network helps show where Rachel Kerr may publish in the future.
Co-authorship network of co-authors of Rachel Kerr
This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Kerr. A scholar is included among the top collaborators of Rachel Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Kerr. Rachel Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study | 4 |
| 4 | 17 | |
| 5 | 6 | |
| 6 | 13 | |
| 7 | 6 | |
| 8 | 9 | |
| 9 | 343 | |
| 10 | 235 | |
| 11 | 43 | |
| 12 | 69 | |
| 13 | 75 | |
| 14 | 80 | |
| 15 | Capecitabine/irinotecan in colorectal cancer: European early-phase data and planned trials. | 10 |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 63 | |
| 19 | Virus-directed enzyme prodrug therapy using retrovirally delivered E. coli nitroreductase and CB1954 | 2 |
| 20 | 8 |
About Rachel Kerr
Rachel Kerr is a scholar working on Oncology, Pathology and Forensic Medicine and Biotechnology, having authored 153 papers that have together received 6.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (70 papers), Genetic factors in colorectal cancer (44 papers) and Colorectal Cancer Surgical Treatments (28 papers). The work is most often cited by research in Oncology (3.3k citations), Pathology and Forensic Medicine (1.3k citations) and Cancer Research (987 citations). Rachel Kerr has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Rachel Midgley, Lawrence S. Young, Ian Tomlinson, Elaine Johnstone, Axel Walther, Charles Swanton, David A. Anderson, Aristides G. Eliopoulos, J. Herod and D. Fyfe. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.